Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.

Further Reading

Study finds increasing incidence of cancer among adolescents and young adults

Study finds increasing incidence of cancer among adolescents and young adults

1 Dec 2020
Study describes the role of Zmat3 in lymphoma and lung cancer development

Study describes the role of Zmat3 in lymphoma and lung cancer development

30 Nov 2020
Researchers study the role of viral intramembrane interactions in controlling programmed cell death

Researchers study the role of viral intramembrane interactions in controlling programmed cell death

27 Nov 2020
Combining cell engineering with machine learning to design living medicines for cancer

Combining cell engineering with machine learning to design living medicines for cancer

26 Nov 2020
Cell survival protein could protect kidneys from damage caused by cancer therapies

Cell survival protein could protect kidneys from damage caused by cancer therapies

25 Nov 2020
Japanese woman diagnosed with frosted branch angiitis

Japanese woman diagnosed with frosted branch angiitis

10 Nov 2020
Study sheds light on the high burden of late effects among young survivors of acute myeloid leukemia

Study sheds light on the high burden of late effects among young survivors of acute myeloid leukemia

9 Nov 2020
‘His lies are killing my neighbors’: Swing-state health workers try to defeat Trump

‘His lies are killing my neighbors’: Swing-state health workers try to defeat Trump

2 Nov 2020
Beat AML trial achieves primary endpoint

Beat AML trial achieves primary endpoint

28 Oct 2020
Inflammasome may play a key role in triggering immune response to cancer

Inflammasome may play a key role in triggering immune response to cancer

27 Oct 2020
Radiation therapy before CART-BCMA appears to be a safe option for multiple myeloma patients

Radiation therapy before CART-BCMA appears to be a safe option for multiple myeloma patients

27 Oct 2020
Cell nucleus may play role in enabling cells to evade crowded environments

Cell nucleus may play role in enabling cells to evade crowded environments

19 Oct 2020
A strategic collaboration to speed up the development of allogeneic cell therapies

A strategic collaboration to speed up the development of allogeneic cell therapies

16 Oct 2020
Moffitt study uncovers how specific molecules promote cancer progression

Moffitt study uncovers how specific molecules promote cancer progression

15 Oct 2020
Researchers are developing a new class of compounds against various cancers

Researchers are developing a new class of compounds against various cancers

14 Oct 2020
CAR NKT cells offer a promising approach to combat hard-to-treat solid tumors

CAR NKT cells offer a promising approach to combat hard-to-treat solid tumors

13 Oct 2020
Study shows how mutations in VAV1 gene may promote T-cell tumors in experimental mice

Study shows how mutations in VAV1 gene may promote T-cell tumors in experimental mice

12 Oct 2020
A new therapeutic approach for Epstein-Barr virus-associated tumors

A new therapeutic approach for Epstein-Barr virus-associated tumors

12 Oct 2020
Novel radioimmunotherapy proven effective in reversing resistance to lymphoma therapy

Novel radioimmunotherapy proven effective in reversing resistance to lymphoma therapy

8 Oct 2020
FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

8 Oct 2020

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback